Comprehensive antibody discovery and engineering services to help you identify, optimize and characterize new leads and deliver molecules demonstrating the desired functionality and reactivity.
Antibody production via transient CHO, HEK293 and other expression platforms at milligrams to gram quantities. Unparalleled analytical capability to enhance recombinant antibody quality.
Full-scale capabilities from molecular design and construction to performing expression purification and characterization across mammalian, microbial and baculovirus systems.
Single B cell with the Berkeley Lights Beacon® Optofluidic System
Commercial mindset from the start to accelerate timelines to clinic.
Our platform uses its proprietary cell line, custom stable expression vectors, and glutamine synthetase (GS) selection technology, maximizing purity and yield while minimizing the time between development and toxicology studies.
Wide range of molecular, biochemical and cell-based bioassays
Comprehensive method development meeting USP, Ph. Eur., and FDA guidelines
Expertise from discovery to cGxP therapeutic testing for all service types
Fully integrated formulation development programs that emphasize critical quality attributes with ICH stability guidelines and manufacturability in mind
End-to-end solutions covering mRNA synthesis, formulation and lipid nanoparticle fill-finish
Our complete suite of services and solutions for mRNA, monoclonal antibodies and recombinant proteins.
Our Hopkinton, MA facility is ISO 13485:2016 certified and provides biomanufacturing services for GMP and BPG production of mRNA, protein therapeutics and vaccines, and therapeutic antibodies.
Our Glasgow, UK and Camarillo, CA sites offer expertise and capabilities for sterile drug product manufacturing from early clinical through large-scale supply.
A demonstrated track record with simple and complex liquid, suspension, and lyophilized products
Continuity of cGMP and scale supported by a single organization, minimizing tech transfer costs and timelines while retaining product knowledge
The ability to solve cGMP production challenges through seamless integration with scientists and process engineers
cGMP manufacturing at scales from 10 L to 2000 L into vials or syringes
With over 30 years of experience formulating both large and small molecules for injection, we can identify the quality attributes that impact the clinical performance and safety of formulations, analyze the manufacturability of dosage forms, and assess stability in primary packaging. Watch video
Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.